Literature DB >> 32557379

The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study.

Juan Wang1,2, Yulong Zhang1,2, Yating Yang1,2, Zhiwei Liu1,2, Lei Xia1,2, Wenzheng Li3, Zhongxiang Li4, Xinhui Xie5, Wenfeng Deng5, Kai Zhang6,7, Huanzhong Liu8,9.   

Abstract

BACKGROUND: Few studies have investigated the weight of patients with schizophrenia in China.
OBJECTIVE: The aim of this study was to analyse the prevalence, clinical characteristics and influencing factors of obesity and underweight in patients with chronic schizophrenia in China.
METHODS: A total of 325 patients with schizophrenia and 172 sex- and age-matched healthy controls from the community were recruited. Socio-demographic data and laboratory measurements were collected for all subjects. Using the Positive and Negative Syndrome Scale (PANSS), we evaluated the psychiatric symptoms of patients with schizophrenia. According to the body mass index (BMI) criteria in China, BMI ≥ 28 kg/m2 indicates obesity, and BMI < 18.5 kg/m2 indicates underweight.
RESULTS: Of the patients with schizophrenia, 16.3% were obese, and 6.8% were underweight; 11.0% of the healthy controls were obese, and 3.5% were underweight. There was no difference between the two groups in the prevalence of obesity and underweight. After controlling for relevant variables, the obesity rate remained non significant, but the underweight rate appeared to be different. The multinomial regression analysis revealed that among the patients with schizophrenia, female sex, triglyceride level and LDL level were independent risk factors for obesity and that HDL level was an independent protective factor against obesity. In contrast, male sex and HDL level were independent risk factors for underweight.
CONCLUSION: We found that the patients with schizophrenia had an increased rate of underweight and some factors related to weight. LEVEL OF EVIDENCE: Level V, descriptive study.

Entities:  

Keywords:  BMI; Blood lipid; Obesity; Schizophrenia; Underweight

Year:  2020        PMID: 32557379     DOI: 10.1007/s40519-020-00920-9

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  58 in total

1.  Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness.

Authors:  Joseph C Ratliff; Laura B Palmese; Erin L Reutenauer; Vinod H Srihari; Cenk Tek
Journal:  Psychosomatics       Date:  2012-06-02       Impact factor: 2.386

2.  Twenty-five year mortality of a community cohort with schizophrenia.

Authors:  Steve Brown; Miranda Kim; Clemence Mitchell; Hazel Inskip
Journal:  Br J Psychiatry       Date:  2010-02       Impact factor: 9.319

3.  [Surgical results in recurrent inguinal hernias].

Authors:  Iu A Nesterenko; G G Serochkin; A S Aboev
Journal:  Vestn Khir Im I I Grek       Date:  1986-02

Review 4.  Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.

Authors:  Cornelis J Roos; Paul H A Quax; J Wouter Jukema
Journal:  Biomark Med       Date:  2012-02       Impact factor: 2.851

Review 5.  Obesity and Cardiovascular Disease.

Authors:  Francisco B Ortega; Carl J Lavie; Steven N Blair
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 6.  Excess early mortality in schizophrenia.

Authors:  Thomas Munk Laursen; Merete Nordentoft; Preben Bo Mortensen
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

7.  Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.

Authors:  Christoph U Correll; Delbert G Robinson; Nina R Schooler; Mary F Brunette; Kim T Mueser; Robert A Rosenheck; Patricia Marcy; Jean Addington; Sue E Estroff; James Robinson; David L Penn; Susan Azrin; Amy Goldstein; Joanne Severe; Robert Heinssen; John M Kane
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

8.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  Davy Vancampfort; Brendon Stubbs; Alex J Mitchell; Marc De Hert; Martien Wampers; Philip B Ward; Simon Rosenbaum; Christoph U Correll
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

Review 9.  Vascular biology of ageing-Implications in hypertension.

Authors:  Adam Harvey; Augusto C Montezano; Rhian M Touyz
Journal:  J Mol Cell Cardiol       Date:  2015-04-17       Impact factor: 5.000

10.  Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level.

Authors:  Karen Kearns; Anne Dee; Anthony P Fitzgerald; Edel Doherty; Ivan J Perry
Journal:  BMC Public Health       Date:  2014-02-10       Impact factor: 3.295

View more
  5 in total

1.  Influencing factors of obesity in community patients with deficit schizophrenia: a cross-sectional study.

Authors:  Na Yong; Jiyang Pan; Xuehua Li; Ling Yu; Xin Hou
Journal:  Eur J Med Res       Date:  2022-06-11       Impact factor: 4.981

2.  APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients.

Authors:  Wei Li; Fengju Liu; Rui Liu; Xinmei Zhou; Guanjun Li; Shifu Xiao
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

3.  ATP-binding cassette transporter 13 mRNA expression level in schizophrenia patients.

Authors:  Lu Qian; Yu Qin; Xinyu Chen; Fuquan Zhang; Bixiu Yang; Kunlun Dong; Zhiqiang Wang; Kai Zhang
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

4.  Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study.

Authors:  Zhiwei Liu; Yulong Zhang; Juan Wang; Lei Xia; Yating Yang; Liang Sun; Dapeng Zhang; Wenzheng Li; Xianhu Yao; Rongchun Yang; Yun Liu; Huanzhong Liu
Journal:  Front Psychiatry       Date:  2022-08-25       Impact factor: 5.435

5.  Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey.

Authors:  Juan Wang; Feng Jiang; Yating Yang; Yulong Zhang; Zhiwei Liu; Xiaorong Qin; Xueqin Tao; Tingfang Liu; Yuanli Liu; Yi-Lang Tang; Huanzhong Liu; Robert O Cotes
Journal:  BMC Psychiatry       Date:  2021-07-27       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.